← Leaderboards
Vidya Mave
Johns Hopkins University
$2,647,198
Attributed
$5,134,543
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,134,543 · 4
By mechanism
R01$3,885,021 · 2
R56$817,252 · 1
R21$432,270 · 1
Top collaborators
- Jonathan E Golub5 shared
- Felicia C. Chow1 shared
- Kelly E. Dooley1 shared
- Olivier Marcy1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Peter A Calabresi$20,846,075
- Melania Maria Bembea$4,528,092
- Vivian F. Go$15,157,279
- David Wesley Dowdy$17,286,098
- Amita Gupta$24,858,182
Others in their field
Top investigators on “Mortality”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$293,517,891
- Lawrence Corey · Fred Hutchinson Cancer Center$289,968,959
- Judith S. Currier · University Of California Los Angeles$286,517,393
- James Dennis Neaton · Northwestern University$278,695,034
- Chanza Baytop · Westat, Inc.$271,217,917
- Daniel R Kuritzkes · Brigham And Women'S Hospital$261,859,249
Research focus
MortalityTuberculosisTuberculosis TreatmentCollectionCollaborationsIndiaHigh RiskRecurrenceVisitCostFollow-UpEpidemicResourcesRespiratoryDiagnosticScreeningProgramsRandomized TrialRecommendationSputumDiagnosisDetectionFutureCost Estimate
Grant awards (9)
Reimagining the IMAGINE-TBM trial: Using metagenomics and host transcriptomics to improve our ability to diagnose tuberculous meningitis and assess response to treatment in a randomized clinical trial$747,881
R01 · FY2025 · NS
TB Aftermath$588,454
R01 · FY2025 · AI
TB Aftermath$595,527
R01 · FY2024 · AI
Investigating Multiple PK and PD Relationships for TB-HIV (IMPPRove TB-HIV)$817,252
R56 · FY2023 · AI
TB Aftermath$625,680
R01 · FY2022 · AI
TB Aftermath$631,996
R01 · FY2021 · AI
TB Aftermath$695,483
R01 · FY2020 · AI
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response in Patients with HIV$228,555
R21 · FY2017 · AI · contact PI
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response in Patients with HIV$203,715
R21 · FY2016 · AI · contact PI